REG - Animalcare Group PLC - Completion of Randlab acquisition

AnimalcareAnnouncement

03/01/2025 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250103:nRSC0915Sa&default-theme=true

RNS Number : 0915S  Animalcare Group PLC  03 January 2025

Animalcare Group Plc

(the "Company" or the "Group")

Completion of Randlab acquisition

3 January 2025. The Board of Animalcare Group plc (AIM: ANCR), the
international animal health business, is pleased to announce that, further to
the Company's announcement on 3 December 2024, the acquisition of Randlab has
completed today.

 

For further information, please contact:

 Animalcare Group Plc                                            +44 (0)1904 487 687

 Chris Brewster, Chief Financial Officer and Company Secretary   communications@animalcaregroup.com
 Stifel Nicolaus Europe Limited                                  Tel: +44 (0)20 7710 7600

 (Nominated Advisor & Joint Broker)

 Ben Maddison

 Nicholas Harland

 Francis North

 Panmure Liberum                                                 +44 (0)20 7886 2500

 (Joint Broker)

 Corporate Finance

 Freddy Crossley/Emma Earl

 Corporate Banking

 Rupert Dearden

 

About Animalcare

Animalcare Group plc is a UK AIM-listed
international development-focused veterinary sales and marketing
organisation. Animalcare operates in seven countries and exports to
approximately 40 countries in Europe and worldwide. The Group is focused on
bringing new and innovative products to market through its own development
pipeline, partnerships and via acquisition.

For more information, please visit www.animalcaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQSSSFSDEISEFF